DOCSLIB.ORG

AGK ELISA Kit (Human) (OKCD00496) Instructions for Use

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
AGK ELISA Kit (Human) (OKCD00496) Instructions for Use AGK ELISA Kit (Human) (OKCD00496) Instructions for use For the quantitative measurement of AGK in tissue homogenates and other biological fluids This product is intended for research use only. AGK ELISA Kit (Human) (OKCD00496) Table of Contents 1. Background ............................................................................................................................ 2 2. Assay Summary ..................................................................................................................... 3 3. Storage and Stability .............................................................................................................. 3 4. Kit Components ...................................................................................................................... 3 5. Precautions ............................................................................................................................ 4 6. Required Materials Not Supplied ............................................................................................ 4 7. Technical Application Tips ...................................................................................................... 4 8. Reagent Preparation .............................................................................................................. 5 9. Sample Preparation ................................................................................................................ 7 10. Assay Procedure .................................................................................................................... 8 11. Calculation of Results ............................................................................................................. 9 12. Typical Expected Data ........................................................................................................... 9 13. Technical Resources ............................................................................................................ 11 www.avivasysbio.com–888.880.0001 – [email protected] 1 AGK ELISA Kit (Human) (OKCD00496) 1. Background Principle Aviva Systems Biology AGK ELISA Kit (Human) (OKCD00496) is based on standard sandwich enzyme-linked immuno-sorbent assay technology. An antibody specific for AGK has been pre-coated onto a 96-wellplate (12 x 8 Well Strips). Standards or test samples are added to the wells, incubated and removed. A biotinylated detector antibody specific for AGK is added, incubated and followed by washing. Avidin-Peroxidase Conjugate is then added, incubated and unbound conjugate is washed away. An enzymatic reaction is produced through the addition of TMB substrate which is catalyzed by HRP generating a blue color product that changes to yellow after adding acidic stop solution. The density of yellow coloration is read by absorbance at 450 nm and is quantitatively proportional to the amount of sample AGK captured in well. Background Lipid kinase that can phosphorylate both monoacylglycerol and diacylglycerol to form lysophosphatidic acid (LPA) and phosphatidic acid (PA), respectively. Does not phosphorylate sphingosine. Overexpression increases the formation and secretion of LPA, resulting in transactivation of EGFR and activation of the downstream MAPK signaling pathway, leading to increased cell growth. General Specifications General Specifications Range 0.156-10 ng/mL LOD < 0.081 ng/mL (Derived by linear regression of OD 450 of the Mean Blank + 2xSD) Human Acylglycerol kinase, mitochondrial UniProt ID: Q53H12 Specificity GeneID: 55750 Target Alias: Acylglycerol kinase, mitochondrial, FLJ10842, hAGK, HsMuLK, MuLK, MULK, Multiple substrate lipid kinase, Multi-substrate lipid kinase Cross-Reactivity No detectable cross-reactivity with other relevant proteins www.avivasysbio.com–888.880.0001 – [email protected] 2 AGK ELISA Kit (Human) (OKCD00496) 2. Assay Summary 3. Storage and Stability • Upon receipt store kit at 4°C for 1 month or -20°C for long term storage (exceptions noted below). Avoid any freeze/thaw cycles. 4. Kit Components •The following reagents are the provided contents of the kit. Description Quantity Storage Conditions Anti-AGK Microplate 96 Wells (12 x 8 Well strips) AGK Lyophilized Standard 2 x 10 ng 100X Biotinylated AGK Detector Antibody 1 x 120 µL 100X Avidin-HRP Conjugate 1 x 120 µL 4°C for 6 Months Standard Diluent 1 x 20 mL -20°C for 12 Months Detector Antibody Diluent 1 x 12 mL Conjugate Diluent 1 x 12 mL 30X Wash Buffer 1 x 20 mL Stop Solution 1 x 6 mL Store at 4°C for 12 TMB Substrate 1 x 9 mL Months www.avivasysbio.com–888.880.0001 – [email protected] 3 AGK ELISA Kit (Human) (OKCD00496) 5. Precautions • Read instructions fully prior to beginning use of the assay kit. • Any deviations or modifications from the described method or use of other reagents could result in a reduction of performance. • Reduce exposure to potentially harmful substances by wearing personal protective lab equipment including lab coats, gloves and glasses. • For information on hazardous substances included in the kit please refer to the Material Safety Data Sheet (MSDS). • Kit cannot be used beyond the expiration date on the label. 6. Required Materials Not Supplied • Microplate reader capable of reading absorbance at 450 nm. • Automated plate washer (optional). • Pipettes capable of precisely dispensing 0.5 µL through 1 mL volumes of aqueous solutions. • Pipettes or volumetric glassware capable of precisely measuring 1 mL through 100 mL of aqueous solutions. • New, clean tubes and/or micro-centrifuge tubes for the preparation of standards or samples. • Absorbent paper or paper toweling. • Distilled or deionized ultrapure water. • 37°C Incubator (optional) 7. Technical Application Tips • Do not mix or substitute components from other kits. • To ensure the validity of experimental operation, it is recommended that pilot experiments using standards and a small selection of sample dilutions to ensure optimal dilution range for quantitation. • Samples exhibiting OD measurements higher than the highest standard should be diluted further in the appropriate sample dilution buffers. • Prior to using the kit, briefly spin component tubes to collect all reagents at the bottom. • Replicate wells are recommended for standards and samples. • Cover microplate while incubating to prevent evaporation. • Do not allow the microplate wells dry at any point during the assay procedure. • Do not reuse tips or tube to prevent cross contamination. • Avoid causing bubbles or foaming when pipetting, mixing or reconstituting. • Completely remove of all liquids when washing to prevent cross contamination. • Prepare reagents immediately prior to use and do not store, with the exception of the top standard. • Equilibrate all materials to ambient room temperature prior to use (standards exception). • For optimal results for inter- and intra-assay consistency, equilibrate all materials to 37°C prior to performing assay (standards exception) and perform all incubations at 37°C. • Pipetting less than 1 µL is not recommended for optimal assay accuracy. • Once the procedure has been started, all steps should be completed without interruption. Ensure that all reagents, materials and devices are ready at the appropriate time. • Incubation times will affect results. All wells should be handled in the same sequential order and time intervals for optimal results. • Samples containing precipitates, fibrin strands or bilirubin, or are hemolytic or lipemic might cause inaccurate results due to interfering factors. • TMB Substrate is easily contaminated and should be colorless or light blue until added to plate. Handle carefully and protect from light. www.avivasysbio.com–888.880.0001 – [email protected] 4 AGK ELISA Kit (Human) (OKCD00496) 8. Reagent Preparation • Equilibrate all materials to room temperature prior to use and use prepare immediately prior to use. 8.1 Human AGK Assay Standards 8.1.1 Prepare the AGK standards no greater than 2 hours prior to performing experiment. Standards should be held on ice until use in the experiment. 8.1.2 Reconstitute one vial of the provided 10 ng/mL Lyophilized AGK Standard for each experiment. Prepare the stock 10,000 pg/mL Standard by reconstituting one tube of Lyophilized AGK Standard as follows: 8.1.2.1 Gently spin or tap the vial at 6,000 – 10,000 rpm for 30 seconds to collect all material at the bottom. 8.1.2.2 Add 1 mL of Standard Diluent to the vial. 8.1.2.3 Seal the vial then mix gently and thoroughly. 8.1.2.4 Leave the vial at ambient temperature for 15 minutes. 8.1.3 Prepare a set of serially diluted standards as follows: 8.1.3.1 Label tubes with numbers 2 – 8. 8.1.3.2 Use the undiluted 10,000 pg/mL AGK Standard as the high standard point (Tube #1). 8.1.3.3 Add 300 µL of Standard Diluent to Tube #’s 2 – 8. 8.1.3.4 Prepare Standard #2 by adding 300 µL of 10,000 pg/mL AGK (Tube #1) to Tube #2. Mix gently and thoroughly. 8.1.3.5 Prepare Standard #3 by adding 300 µL of Standard #2 from Tube #2 to Tube #3. Mix gently and thoroughly. 8.1.3.6 Prepare further serial dilutions through Tube #7. Reference the table below as a guide for serial dilution scheme. 8.1.3.7 Tube #8 is a blank standard (only Standard Diluent ), which should be included with every experiment. Standard Volume S tandard Volume Standard Total Volume Number Standard To Dilute to Dilute Diluent Buffer Final Concentration (µL) (Tube) (µL) (µL) 10,000 pg/mL 1 Reconstituted AGK 1,000 NA NA 10,000 pg/mL Standard 2 10,000 pg/mL 300 300
Load more

Recommended publications
  • Novel Gene Fusions in Glioblastoma Tumor Tissue and Matched Patient Plasma
    cancers Article Novel Gene Fusions in Glioblastoma Tumor Tissue and Matched Patient Plasma 1, 1, 1 1 1 Lan Wang y, Anudeep Yekula y, Koushik Muralidharan , Julia L. Small , Zachary S. Rosh , Keiko M. Kang 1,2, Bob S. Carter 1,* and Leonora Balaj 1,* 1 Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02115, USA; [email protected] (L.W.); [email protected] (A.Y.); [email protected] (K.M.); [email protected] (J.L.S.); [email protected] (Z.S.R.); [email protected] (K.M.K.) 2 School of Medicine, University of California San Diego, San Diego, CA 92092, USA * Correspondence: [email protected] (B.S.C.); [email protected] (L.B.) These authors contributed equally. y Received: 11 March 2020; Accepted: 7 May 2020; Published: 13 May 2020 Abstract: Sequencing studies have provided novel insights into the heterogeneous molecular landscape of glioblastoma (GBM), unveiling a subset of patients with gene fusions. Tissue biopsy is highly invasive, limited by sampling frequency and incompletely representative of intra-tumor heterogeneity. Extracellular vesicle-based liquid biopsy provides a minimally invasive alternative to diagnose and monitor tumor-specific molecular aberrations in patient biofluids. Here, we used targeted RNA sequencing to screen GBM tissue and the matched plasma of patients (n = 9) for RNA fusion transcripts. We identified two novel fusion transcripts in GBM tissue and five novel fusions in the matched plasma of GBM patients. The fusion transcripts FGFR3-TACC3 and VTI1A-TCF7L2 were detected in both tissue and matched plasma.
    [Show full text]
  • Extending the Phenotypic Spectrum of Sengers Syndrome: Congenital Lactic Acidosis with Synthetic Liver Dysfunction
    Himmelfarb Health Sciences Library, The George Washington University Health Sciences Research Commons Pathology Faculty Publications Pathology 4-13-2018 Extending the phenotypic spectrum of Sengers syndrome: Congenital lactic acidosis with synthetic liver dysfunction. David B Beck Kristina Cusmano-Ozog George Washington University Nickie Andescavage George Washington University Eyby Leon George Washington University Follow this and additional works at: https://hsrc.himmelfarb.gwu.edu/smhs_path_facpubs Part of the Medical Pathology Commons, Pathology Commons, and the Translational Medical Research Commons APA Citation Beck, D., Cusmano-Ozog, K., Andescavage, N., & Leon, E. (2018). Extending the phenotypic spectrum of Sengers syndrome: Congenital lactic acidosis with synthetic liver dysfunction.. Translational Science of Rare Diseases, 3 (1). http://dx.doi.org/10.3233/ TRD-180020 This Journal Article is brought to you for free and open access by the Pathology at Health Sciences Research Commons. It has been accepted for inclusion in Pathology Faculty Publications by an authorized administrator of Health Sciences Research Commons. For more information, please contact [email protected]. Translational Science of Rare Diseases 3 (2018) 45–48 45 DOI 10.3233/TRD-180020 IOS Press Original Research Extending the phenotypic spectrum of Sengers syndrome: Congenital lactic acidosis with synthetic liver dysfunction David B. Becka, Kristina Cusmano-Ozogb, Nickie Andescavagec and Eyby Leonb,∗ aNational Human Genome Research Institute, National Institute of Health, Bethesda, MD, USA bChildren’s National Health System, Rare Disease Institute, Genetics and Metabolism, Washington, DC, USA cChildren’s National Health System, Pediatrics, Neonatology, Washington, DC, USA Abstract. Sengers syndrome is a rare autosomal recessive mitochondrial disease characterized by lactic acidosis, hypertrophic cardiomyopathy and bilateral cataracts.
    [Show full text]
  • Two Novel Mutations in the AGK Gene: Two Case Reports with Sengers
    Techno e lo Kor et al., Gene Technol 2016, 5:1 n g e y G Gene Technology DOI: 10.4172/2329-6682.1000140 ISSN: 2329-6682 Case Report Open Access Two Novel Mutations in the AGK Gene: Two Case Reports with Sengers Syndrome Deniz Kor1*, Berna Seker Yılmaz1, Ozden Ozgur Horoz2, Gulay Ceylaner3, Selcuk Sızmaz4, Fadli Demir2 and Neslihan Onenli Mungan1 1Department of Pediatric Metabolism and Nutrition, Faculty of Medicine, Cukurova University, Adana, Turkey 2Department of Pediatrics, Faculty of Medicine, Cukurova University, Adana, Turkey 3Intergen Genetic Laboratory, Ankara, Turkey 4Department of Ophthalmology, Cukurova University Faculty of Medicine, Adana, Turkey Abstract Mutations in the AGK gene are known to cause Sengers Syndrome, a rare recessive disorder characterized by congenital cataracts, hypertrophic cardiomyopathy, skeletal myopathy, exercise intolerance and lactic acidosis with normal mental development. Since the first report in 1975 by Sengers et al. about 50 individuals have been described as having this syndrome. Here we report two novel mutations in the AGK gene in two patients with neonatal Sengers syndrome. Keywords: AGK gene; Sengers syndrome; Cardiomyopathy; acylcarnitine levels, plasma amino acids and urine organic acids) Myopathy; Cataract were within normal limits except elevated levels of creatine kinases and lactate. Echocardiographic evaluation documented hypertrophic Introduction cardiomyopathy with an ejection fraction of 30%. Electromyography Sengers Syndrome (OMIM 212350), also known as cardiomyopathic and cerebral MRI showed no abnormality. A quadriceps muscle biopsy mitochondrial DNA depletion syndrome-10 (MTDPS10) is a rare revealed fatty infiltrations in the muscle fibers and myopathic changes. autosomal-recessive disorder characterized by congenital cataracts, Based on these observations a clinical diagnosis of Sengers Syndrome hypertrophic cardiomyopathy, skeletal myopathy, exercise intolerance was made.
    [Show full text]
  • Supplemental Information
    Supplemental information Dissection of the genomic structure of the miR-183/96/182 gene. Previously, we showed that the miR-183/96/182 cluster is an intergenic miRNA cluster, located in a ~60-kb interval between the genes encoding nuclear respiratory factor-1 (Nrf1) and ubiquitin-conjugating enzyme E2H (Ube2h) on mouse chr6qA3.3 (1). To start to uncover the genomic structure of the miR- 183/96/182 gene, we first studied genomic features around miR-183/96/182 in the UCSC genome browser (http://genome.UCSC.edu/), and identified two CpG islands 3.4-6.5 kb 5’ of pre-miR-183, the most 5’ miRNA of the cluster (Fig. 1A; Fig. S1 and Seq. S1). A cDNA clone, AK044220, located at 3.2-4.6 kb 5’ to pre-miR-183, encompasses the second CpG island (Fig. 1A; Fig. S1). We hypothesized that this cDNA clone was derived from 5’ exon(s) of the primary transcript of the miR-183/96/182 gene, as CpG islands are often associated with promoters (2). Supporting this hypothesis, multiple expressed sequences detected by gene-trap clones, including clone D016D06 (3, 4), were co-localized with the cDNA clone AK044220 (Fig. 1A; Fig. S1). Clone D016D06, deposited by the German GeneTrap Consortium (GGTC) (http://tikus.gsf.de) (3, 4), was derived from insertion of a retroviral construct, rFlpROSAβgeo in 129S2 ES cells (Fig. 1A and C). The rFlpROSAβgeo construct carries a promoterless reporter gene, the β−geo cassette - an in-frame fusion of the β-galactosidase and neomycin resistance (Neor) gene (5), with a splicing acceptor (SA) immediately upstream, and a polyA signal downstream of the β−geo cassette (Fig.
    [Show full text]
  • Identification of Kinase Fusion Oncogenes in Post-Chernobyl Radiation-Induced Thyroid Cancers
    Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers Julio C. Ricarte-Filho, … , Christopher E. Mason, James A. Fagin J Clin Invest. 2013;123(11):4935-4944. https://doi.org/10.1172/JCI69766. Research Article Exposure to ionizing radiation during childhood markedly increases the risk of developing papillary thyroid cancer. We examined tissues from 26 Ukrainian patients with thyroid cancer who were younger than 10 years of age and living in contaminated areas during the time of the Chernobyl nuclear reactor accident. We identified nonoverlapping somatic driver mutations in all 26 cases through candidate gene assays and next-generation RNA sequencing. We found that 22 tumors harbored fusion oncogenes that arose primarily through intrachromosomal rearrangements. Altogether, 23 of the oncogenic drivers identified in this cohort aberrantly activate MAPK signaling, including the 2 somatic rearrangements resulting in fusion of transcription factor ETS variant 6 (ETV6) with neurotrophic tyrosine kinase receptor, type 3 (NTRK3) and fusion of acylglycerol kinase (AGK) with BRAF. Two other tumors harbored distinct fusions leading to overexpression of the nuclear receptor PPARγ. Fusion oncogenes were less prevalent in tumors from a cohort of children with pediatric thyroid cancers that had not been exposed to radiation but were from the same geographical regions. Radiation-induced thyroid cancers provide a paradigm of tumorigenesis driven by fusion oncogenes that activate MAPK signaling or, less frequently, a PPARγ-driven transcriptional program. Find the latest version: https://jci.me/69766/pdf Related Commentary, page 4566 Research article Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers Julio C.
    [Show full text]
  • University of California Santa Cruz Sample
    UNIVERSITY OF CALIFORNIA SANTA CRUZ SAMPLE-SPECIFIC CANCER PATHWAY ANALYSIS USING PARADIGM A dissertation submitted in partial satisfaction of the requirements for the degree of DOCTOR OF PHILOSOPHY in BIOMOLECULAR ENGINEERING AND BIOINFORMATICS by Stephen C. Benz June 2012 The Dissertation of Stephen C. Benz is approved: Professor David Haussler, Chair Professor Joshua Stuart Professor Nader Pourmand Dean Tyrus Miller Vice Provost and Dean of Graduate Studies Copyright c by Stephen C. Benz 2012 Table of Contents List of Figures v List of Tables xi Abstract xii Dedication xiv Acknowledgments xv 1 Introduction 1 1.1 Identifying Genomic Alterations . 2 1.2 Pathway Analysis . 5 2 Methods to Integrate Cancer Genomics Data 10 2.1 UCSC Cancer Genomics Browser . 11 2.2 BioIntegrator . 16 3 Pathway Analysis Using PARADIGM 20 3.1 Method . 21 3.2 Comparisons . 26 3.2.1 Distinguishing True Networks From Decoys . 27 3.2.2 Tumor versus Normal - Pathways associated with Ovarian Cancer 29 3.2.3 Differentially Regulated Pathways in ER+ve vs ER-ve breast can- cers . 36 3.2.4 Therapy response prediction using pathways (Platinum Free In- terval in Ovarian Cancer) . 38 3.3 Unsupervised Stratification of Cancer Patients by Pathway Activities . 42 4 SuperPathway - A Global Pathway Model for Cancer 51 4.1 SuperPathway in Ovarian Cancer . 55 4.2 SuperPathway in Breast Cancer . 61 iii 4.2.1 Chin-Naderi Cohort . 61 4.2.2 TCGA Breast Cancer . 63 4.3 Cross-Cancer SuperPathway . 67 5 Pathway Analysis of Drug Effects 74 5.1 SuperPathway on Breast Cell Lines .
    [Show full text]
  • Genetic Analyses in a Bonobo (Pan Paniscus) with Arrhythmogenic Right Ventricular Cardiomyopathy Received: 19 September 2017 Patrícia B
    www.nature.com/scientificreports OPEN Genetic analyses in a bonobo (Pan paniscus) with arrhythmogenic right ventricular cardiomyopathy Received: 19 September 2017 Patrícia B. S. Celestino-Soper1, Ty C. Lynnes1, Lili Zhang1, Karen Ouyang1, Samuel Wann2, Accepted: 21 February 2018 Victoria L. Clyde2 & Matteo Vatta1,3 Published: xx xx xxxx Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a disorder that may lead to sudden death and can afect humans and other primates. In 2012, the alpha male bonobo of the Milwaukee County Zoo died suddenly and histologic evaluation found features of ARVC. This study sought to discover a possible genetic cause for ARVC in this individual. We sequenced our subject’s DNA to search for deleterious variants in genes involved in cardiovascular disorders. Variants found were annotated according to the human genome, following currently available classifcation used for human diseases. Sequencing from the DNA of an unrelated unafected bonobo was also used for prediction of pathogenicity. Twenty-four variants of uncertain clinical signifcance (VUSs) but no pathogenic variants were found in the proband studied. Further familial, functional, and bonobo population studies are needed to determine if any of the VUSs or a combination of the VUSs found may be associated with the clinical fndings. Future genotype-phenotype establishment will be benefcial for the appropriate care of the captive zoo bonobo population world-wide as well as conservation of the bobono species in its native habitat. Cardiovascular disease is a leading cause of death for both human and non-human primates, who share similar genomes and many environmental and lifestyle characteristics1. However, while humans most ofen die due to coronary artery disease (CAD), non-human primates living in captivity are more ofen afected by hypertensive cardiomyopathy1.
    [Show full text]
  • Ancestral Grass Karyotype Reconstruction Unravels New Mechanisms of Genome Shuffling As a Source of Plant Evolution
    Downloaded from genome.cshlp.org on September 29, 2021 - Published by Cold Spring Harbor Laboratory Press Research Ancestral grass karyotype reconstruction unravels new mechanisms of genome shuffling as a source of plant evolution Florent Murat,1,4 Jian-Hong Xu,2,4 Eric Tannier,3,4 Michael Abrouk,1 Nicolas Guilhot,1 Caroline Pont,1 Joachim Messing,2,5 and Je´roˆme Salse1,5 1INRA, UMR 1095, Laboratoire Ge´ne´tique, Diversite´ et Ecophysiologie des Ce´re´ales, 63100 Clermont Ferrand, France; 2The Plant Genome Initiative at Rutgers (PGIR), Waksman Institute of Microbiology, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, USA; 3INRIA Rhoˆne-Alpes, Universite´ de Lyon 1, CNRS UMR5558, Laboratoire Biome´trie et Biologie E´volutive, 69622 Villeurbanne Cedex, France The comparison of the chromosome numbers of today’s species with common reconstructed paleo-ancestors has led to intense speculation of how chromosomes have been rearranged over time in mammals. However, similar studies in plants with respect to genome evolution as well as molecular mechanisms leading to mosaic synteny blocks have been lacking due to relevant examples of evolutionary zooms from genomic sequences. Such studies require genomes of species that belong to the same family but are diverged to fall into different subfamilies. Our most important crops belong to the family of the grasses, where a number of genomes have now been sequenced. Based on detailed paleogenomics, using inference from n = 5–12 grass ancestral karyotypes (AGKs) in terms of gene content and order, we delineated sequence intervals comprising a complete set of junction break points of orthologous regions from rice, maize, sorghum, and Brachypodium genomes, representing three different subfamilies and different polyploidization events.
    [Show full text]
  • Hereditary Renal Cell Carcinoma in the Rat Associated with Nonrandom Loss of Chromosomes 5 and 61
    [CANCER RESEARCH 5l. 4415-4422, August 15. 1991| Hereditary Renal Cell Carcinoma in the Rat Associated with Nonrandom Loss of Chromosomes 5 and 61 Kenji Funaki,2 Jeffrey Everitt, Mitsuo Oshimura, Jerome J. Freed, Alfred G. Knudson, Jr., and Cheryl Walker1 Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina 27709 ¡K.F.,J. £.,C. W.]; Tottori L'niversity, Yonago, Japan ¡M.O./; and Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 fJ. J. F., A. G. K.] ABSTRACT A large body of work exists documenting the induction of RCC in rats by various chemical carcinogens (1), although the A spontaneous form of renal cell carcinoma occurs in rats that arises use of these animals as models for studying the mechanism of as the result of the inheritance of a mutation in a single autosomal gene. Cytogenetic analysis was performed on seven cell lines and four primary RCC and extrapolating this information to humans have been tumor cell preparations derived from this hereditary form of renal cell limited by the fact that spontaneous RCC in rats is very rare carcinoma. Banded karyotypes prepared from these seven lines exhibited (28). However, a line of Long-Evans rats has been developed loss and/or partial deletion of both chromosomes 5 and 6. Translocations that carries a single gene mutation that predisposes to renal involving chromosome 4, resulting in a net loss of genetic material located cell carcinoma (29). The mutation has an autosomal dominant near the centromere (4qll), were observed in three of the cell lines. pattern of inheritance with 100% penetrance (30).
    [Show full text]
  • Kinase Gene Fusions in Melanoma by Jacqueline Turner a Thesis
    i Kinase Gene Fusions in Melanoma by Jacqueline Turner A thesis submitted to the Faculty of the Undergraduate School of the University of Colorado in partial fulfillment of graduating with Honors from the Department of Chemistry and Biochemistry 2017 i This thesis entitled: Recurrent Kinase Gene Fusions in Melanoma Written by Jacqueline Turner has been approved for the Department of Chemistry and Biochemistry _________________________________ _________________________________ Dr. Joseph Falke Dr. Robert Parson _________________________________ _________________________________ Dr. Jennifer Martin Dr. Natalie Ahn _________________________________ _________________________________ Dr. John Tentler Dr. William Robinson Date:_______________________ The final copy of this thesis has been examined by the signatories, and we find that both the content and the form meet acceptable presentation standards of scholarly work in the above mentioned discipline ii Turner, Jacqueline (B.A., Department of Chemistry and Biochemistry) Kinase Fusions in Melanoma Thesis directed by Professor William Robinson Kinase gene fusions are a mechanism of alternative pathway activation and have been increasingly described in cancer, including malignant melanoma. The prevalence of kinase gene fusions across different subtypes in melanoma has not yet been reported. Additionally, few studies in melanoma have examined the responses of these kinase gene fusions to small molecule inhibitors. We used break-apart fluorescence in situ hybridization (FISH) to identify genomic rearrangements in tissues from 59 patients with various types of malignant melanoma including acral lentiginous, mucosal, superficial spreading, and nodular. We identified four genomic rearrangements involving the genes BRAF, RET, and ROS1. Of these, three were confirmed by immunohistochemistry (IHC) or sequencing. We identified a RET fusion in an acral lentiginous melanoma, an ARMC10-BRAF fusion in an unknown primary melanoma, and an AGK-BRAF fusion in a superficial spreading melanoma.
    [Show full text]
  • Biomolecules
    biomolecules Review Biogenesis of Mitochondrial Metabolite Carriers Patrick Horten 1,2, Lilia Colina-Tenorio 1,3 and Heike Rampelt 1,3,* 1 Institute of Biochemistry and Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany; [email protected] (P.H.); [email protected] (L.C.-T.) 2 Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany 3 CIBSS Centre for Integrative Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany * Correspondence: [email protected] Received: 10 June 2020; Accepted: 3 July 2020; Published: 7 July 2020 Abstract: Metabolite carriers of the mitochondrial inner membrane are crucial for cellular physiology since mitochondria contribute essential metabolic reactions and synthesize the majority of the cellular ATP. Like almost all mitochondrial proteins, carriers have to be imported into mitochondria from the cytosol. Carrier precursors utilize a specialized translocation pathway dedicated to the biogenesis of carriers and related proteins, the carrier translocase of the inner membrane (TIM22) pathway. After recognition and import through the mitochondrial outer membrane via the translocase of the outer membrane (TOM) complex, carrier precursors are ushered through the intermembrane space by hexameric TIM chaperones and ultimately integrated into the inner membrane by the TIM22 carrier translocase. Recent advances have shed light on the mechanisms of TOM translocase and TIM chaperone
    [Show full text]
  • Hippocampal Transcriptomic and Proteomic Alterations in the BTBR Mouse Model of Autism Spectrum Disorder
    ORIGINAL RESEARCH published: 24 November 2015 doi: 10.3389/fphys.2015.00324 Hippocampal Transcriptomic and Proteomic Alterations in the BTBR Mouse Model of Autism Spectrum Disorder Caitlin M. Daimon 1, Joan M. Jasien 1, William H. Wood III 2, Yongqing Zhang 2, Kevin G. Becker 2, Jill L. Silverman 3, 4, Jacqueline N. Crawley 3, 4, Bronwen Martin 1 and Stuart Maudsley 5, 6, 7* 1 Metabolism Unit, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA, 2 Gene Expression and Genomics Unit, National Institutes of Health, Baltimore, MD, USA, 3 Laboratory of Behavioral Neuroscience, Intramural Research Program, National Institute of Mental Health, Bethesda, MD, USA, 4 MIND Institute, University of California Davis School of Medicine, Sacramento, CA, USA, 5 Receptor Pharmacology Unit, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA, 6 Translational Neurobiology Group, VIB Department of Molecular Genetics, University of Antwerp, Antwerp, Belgium, 7 Laboratory of Neurogenetics, Institute Born-Bunge, University of Antwerp, Antwerpen, Belgium Edited by: Autism spectrum disorders (ASD) are complex heterogeneous neurodevelopmental Ovidiu Constantin Baltatu, Camilo Castelo Branco University, disorders of an unclear etiology, and no cure currently exists. Prior studies have Brazil demonstrated that the black and tan, brachyury (BTBR) T+ Itpr3tf/J mouse strain Reviewed by: displays a behavioral phenotype with ASD-like features. BTBR T+ Itpr3tf/J mice (referred Rodrigo N. Romcy-Pereira, to simply as BTBR) display deficits in social functioning, lack of communication ability, Universidade Federal do Rio Grande do Norte, Brazil and engagement in stereotyped behavior. Despite extensive behavioral phenotypic Rupert W. Overall, characterization, little is known about the genes and proteins responsible for the Technische Universität Dresden, Germany presentation of the ASD-like phenotype in the BTBR mouse model.
    [Show full text]